DK675389D0 - Terapeutiske praeparater til forebyggelse af fibrinaflejringer - Google Patents

Terapeutiske praeparater til forebyggelse af fibrinaflejringer

Info

Publication number: DK675389D0
Authority: DK; Denmark
Prior art keywords: fibrine; fleets; prevention; therapeutic preparations; preparations
Prior art date: 1987-07-01

Application number

DK675389A

Other languages

English (en)

Other versions

DK675389A (da

DK175597B1 (da

Inventor

Marjorie A Mohler

Tue H Nguyen

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-01

Filing date

1989-12-29

Publication date

1989-12-29

1989-12-29 Application filed by Genentech Inc filed Critical Genentech Inc

1989-12-29 Publication of DK675389D0 publication Critical patent/DK675389D0/da

1990-02-28 Publication of DK675389A publication Critical patent/DK675389A/da

2004-12-13 Application granted granted Critical

2004-12-13 Publication of DK175597B1 publication Critical patent/DK175597B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK198906753A 1987-07-01 1989-12-29 Anvendelse af en vævsplasminogenaktivator (t-PA) til fremstilling af et præparat til anvendelse til forebyggelse af fibrinaflejring eller adhærencedannelse eller -gendannelse, topiske præparater og dispenseringsindretninger til. DK175597B1 (da)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
US6887287A	1987-07-01	1987-07-01
US6887287		1987-07-01
US12531987A	1987-11-25	1987-11-25
US12531987		1987-11-25
US21089588A	1988-06-24	1988-06-24
US21089588		1988-06-24
US8802194		1988-06-30
PCT/US1988/002194 WO1989000049A1 (en)	1987-07-01	1988-06-30	Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Publications (3)

Publication Number	Publication Date
DK675389D0 true DK675389D0 (da)	1989-12-29
DK675389A DK675389A (da)	1990-02-28
DK175597B1 DK175597B1 (da)	2004-12-13

Family

ID=27371438

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK198906753A DK175597B1 (da)	1987-07-01	1989-12-29	Anvendelse af en vævsplasminogenaktivator (t-PA) til fremstilling af et præparat til anvendelse til forebyggelse af fibrinaflejring eller adhærencedannelse eller -gendannelse, topiske præparater og dispenseringsindretninger til.

Country Status (14)

Country	Link
EP (1)	EP0297860B1 (da)
JP (1)	JP2756131B2 (da)
KR (1)	KR0131330B1 (da)
AU (1)	AU621305B2 (da)
DE (1)	DE3883645T2 (da)
DK (1)	DK175597B1 (da)
FI (1)	FI103868B (da)
IE (1)	IE65658B1 (da)
IL (2)	IL86933A (da)
NO (1)	NO301748B1 (da)
NZ (1)	NZ225260A (da)
PH (1)	PH26527A (da)
PT (1)	PT87886B (da)
WO (1)	WO1989000049A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5364622A (en) *	1987-12-04	1994-11-15	Dr. Karl Thomae Gmbh	Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
DE3741149A1 (de) *	1987-12-04	1989-06-15	Thomae Gmbh Dr K	Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
AU7073994A (en) *	1993-07-02	1995-01-24	Quest International B.V.	Packaging of enzymes
US5869810A (en) *	1995-05-23	1999-02-09	Victor Reynolds	Impedance-heated furnace
DE19529223A1 (de) *	1995-08-09	1997-02-13	Boehringer Mannheim Gmbh	Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) *	1996-11-27	1998-11-17	Gelfand; Mathew I.	Use of thrombolytic reagents for prevention of vascular disease
WO1999024062A1 (en) *	1997-11-07	1999-05-20	Chiron Corporation	Novel igf-i composition and its use
US7067485B2 (en)	1997-11-07	2006-06-27	Chiron Corporation	IGF-I composition and its use
FR2918276B1 (fr) *	2007-07-02	2010-01-22	Anteis Sa	"utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de)	2014-08-26	2016-03-03	Akesion Gmbh	Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1229075B (it) *	1985-04-05	1991-07-17	Fidia Farmaceutici	Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) *	1985-01-05	1986-07-10	Hoechst Ag, 6230 Frankfurt	Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) *	1985-07-18	1987-01-27	Sony Corp	ヒ−トシンクの製造方法
NZ217844A (en) *	1985-10-11	1989-10-27	Sumitomo Pharma	A sustained release pharmaceutical composition containing silicone elastomer and an albumin
ZA869434B (en) *	1985-12-16	1988-07-27	Ethicon Inc	Method for inhibiting post-surgical adhesion formation by the topical administration of tussue plasminogen activator

1988
- 1988-06-30 IL IL86933A patent/IL86933A/xx not_active IP Right Cessation
- 1988-06-30 DE DE88305935T patent/DE3883645T2/de not_active Expired - Lifetime
- 1988-06-30 WO PCT/US1988/002194 patent/WO1989000049A1/en active IP Right Grant
- 1988-06-30 KR KR1019890700376A patent/KR0131330B1/ko not_active IP Right Cessation
- 1988-06-30 EP EP88305935A patent/EP0297860B1/en not_active Expired - Lifetime
- 1988-06-30 PT PT87886A patent/PT87886B/pt not_active IP Right Cessation
- 1988-06-30 AU AU19985/88A patent/AU621305B2/en not_active Expired
- 1988-06-30 JP JP63505978A patent/JP2756131B2/ja not_active Expired - Lifetime
- 1988-07-01 PH PH37149A patent/PH26527A/en unknown
- 1988-07-01 NZ NZ225260A patent/NZ225260A/en unknown
- 1988-07-01 IE IE202388A patent/IE65658B1/en not_active IP Right Cessation
1989
- 1989-12-29 DK DK198906753A patent/DK175597B1/da not_active IP Right Cessation
- 1989-12-29 NO NO895338A patent/NO301748B1/no not_active IP Right Cessation
- 1989-12-29 FI FI896359A patent/FI103868B/fi active IP Right Grant
1992
- 1992-07-23 IL IL102625A patent/IL102625A0/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0297860B1 (en)	1993-09-01
KR0131330B1 (ko)	1998-04-17
FI103868B1 (fi)	1999-10-15
AU1998588A (en)	1989-01-30
IE65658B1 (en)	1995-11-15
DK675389A (da)	1990-02-28
NO301748B1 (no)	1997-12-08
FI103868B (fi)	1999-10-15
WO1989000049A1 (en)	1989-01-12
PT87886A (pt)	1989-06-30
JP2756131B2 (ja)	1998-05-25
EP0297860A1 (en)	1989-01-04
NZ225260A (en)	1991-03-26
NO895338L (no)	1990-02-28
KR890701124A (ko)	1989-12-19
NO895338D0 (no)	1989-12-29
AU621305B2 (en)	1992-03-12
FI896359A0 (fi)	1989-12-29
DE3883645D1 (de)	1993-10-07
IL86933A (en)	1993-07-08
DE3883645T2 (de)	1994-02-03
DK175597B1 (da)	2004-12-13
IL102625A0 (en)	1993-01-14
PT87886B (pt)	1993-09-30
JPH04502753A (ja)	1992-05-21
PH26527A (en)	1992-08-07
IE882023L (en)	1989-01-01

Publication	Publication Date	Title
FI891076L (fi)	1989-03-07	Transdermaalinen terapeuttinen järjestelmä
DK437188D0 (da)	1988-08-04	Fremgangsmaade til kryopreservering af hjerteklapper
NO864879L (no)	1987-06-09	Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO862373D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
DK397388A (da)	1989-02-09	Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
DK675389D0 (da)	1989-12-29	Terapeutiske praeparater til forebyggelse af fibrinaflejringer
DK427281A (da)	1981-09-25	Fremgangsmaade til fremstilling af terapeutiske praeparater
DK226488D0 (da)	1988-04-26	Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
NO865028L (no)	1987-06-15	Fremgangsmaate for fremstilling av et terapeutisk system.
DK271588D0 (da)	1988-05-18	Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK537687D0 (da)	1987-10-14	Fremgangsmaade til fremstilling af n-substituerede piperazinoner
NO164899C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
DK240989A (da)	1989-11-20	2-halogen-4,5-difluorbenzoesyre-forbindelser og fremgangsmaader til fremstilling deraf samt fremgangsmaade til fremstilling af 1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyreestere
DK28788D0 (da)	1988-01-22	Fremgangsmaade til fremstilling af alkansulfonamider
DK0458855T3 (da)	1996-09-30	Farmaceutisk præparat til behandling af tonsillitis
DK601489D0 (da)	1989-11-29	Fremgangsmaade til fremstilling af alkansulfonamider
DK500589D0 (da)	1989-10-10	Farmaceutisk praeparat til behandling af lungeobstruktioner
DK106589A (da)	1989-05-08	Fremgangsmaade til fremstilling af aenaturligtae methylanthranilat
DK97388A (da)	1988-08-26	Mellemprodukt og fremgangsmaade til fremstilling af antihypercholestrolemiske tetrazolforbindelser
DK4488D0 (da)	1988-01-06	Fremgangsmaade til fremstilling af krystallinsk aminobeskyttet beta-benzyl-l-asparaginsyre
DK142788D0 (da)	1988-03-16	Fremgangsmaade til fremstilling af chlorerede olefiner
DK68790D0 (da)	1990-03-16	Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK162789D0 (da)	1989-04-05	Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK646188A (da)	1988-11-18	Fremgangsmaade til fremstilling af halogenalkyllactamer
DK492686D0 (da)	1986-10-15	Vacumtelt til terapeutisk behandling

Legal Events

Date	Code	Title	Description
2008-07-21	PUP	Patent expired